ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CDXS vs LIN // 10Y YIELD & FRED MACRO BETA

Codexis Inc. (NASDAQ) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: CDXS 1 — LIN 9
■ METRIC PARITY
macro-sensitivity
—
macro-sensitivity
1.01
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDXS VS. LIN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CDXS LIN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 86.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 13.10% -48.10 LIN /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield -17.85% 2.19% -20.04 LIN /fcf-yield <GO>
Operating Margin -59.30% 26.30% -85.60 LIN /operating-margins <GO>
Net Profit Margin -60.00% 20.30% -80.30 LIN /net-margins <GO>
Revenue Growth (YoY) 18.60% 3.00% +15.60 CDXS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 1.21% -1.21 LIN /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 3.93 -3.73 LIN /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 LIN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.9 56.6 -15.70 LIN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 1.01 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 31.2x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $133.6M $231.94B -$231.81B LIN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CDXS REV LIN REV CDXS GROSS % LIN GROSS % CDXS FCF LIN FCF
FY 2025 $70.4M $33.99B 86.7% — -$23.8M $5.09B
FY 2024 $59.3M $33.01B 72.6% — -$53.7M $4.93B
FY 2023 $70.1M $32.85B — — -$52.6M $7.83B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDXS // BETA —
LIN // BETA 1.01